Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells

Oncogene

Volumn 26, Issue 35, 2007, Pages 5060-5069

  Kehn, K ^a   Berro, R ^a   Alhaj, A ^a   Bottazzi, M E ^b   Yeh, W I ^a   Klase, Z ^a   Van Duyne, R ^a   Fu, S ^a   Kashanchi, F ^a,b,c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c J CRAIG VENTER INSTITUTE   (United States)

Author keywords

BRCA1; cdk4; Cyclin D1; Phosphorylation; Transcription

Indexed keywords

BRCA1 PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; SERINE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

AMINO ACID SEQUENCE; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; DNA; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS);

EID: 34547623732     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210319     Document Type: Article

References (32)

1. Aubry C, Jenkins PR, Mahale S, Chaudhuri B, Marechal JD, Sutcliffe MJ. (2004). New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity. Chem Commun 15: 1696-1697.
2. Boulton SJ. (2006). Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans 34: 633-645.
3. Cable PL, Wilson CA, Calzone FJ, Rauscher III FJ, Scully R, Livingston DM et al. (2003). Novel consensus DNA-binding sequence for BRCA1 protein complexes. Mol Carcinog 38: 85-96.
4. Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH. (1996). BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56: 3168-3172.
5. Coqueret O. (2002). Linking cyclins to transcriptional control. Gene 299: 35-55.
6. Cortez D, Wang Y, Qin J, Elledge SJ. (1999). Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286: 1162-1166.
7. de La Fuente C, Santiago F, Chong SY, Deng L, Mayhood T, Fu P et al. (2000). Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2. J Virol 16: 7270-7283.
8. Fabbro M, Rodriguez JA, Baer R, Henderson BR. (2002). BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export. J Biol Chem 277: 21315-21324.
9. Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA et al. (2002). p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res 62: 141-151.
10. Hejna M, Schmidinger M, Raderer M. (2002). The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? Ann Oncol 13: 653-668.
11. Hillion J, Le Coniat M, Jonveaux P, Berger R, Bernard OA. (1997). AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 90: 3714-3719.
12. Katoh M, Katoh M. (2004). Human FOX gene family. Int J Oncol 25: 1495-1500.
13. Kehn K, Deng L, de la Fuente C, Strouss K, Wu K, Maddukuri A et al. (2004). The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology 1: 6.
14. Lacroix M, Leclercq G. (2004). Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289.
15. Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R et al. (2002). The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res 62: 5273-5279.
16. Mark WY, Liao JC, Lu Y, Ayed A, Laister R, Szymczyna B et al. (2005). Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J Mol Biol 345: 275-287.
17. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. (2004). Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430: 226-231.
18. Moisan A, Gaudreau L. (2006). The BRCA1 COOH-terminal region acts as an RNA polymerase II carboxyl-terminal domain kinase inhibitor that modulates p21WAF1/CIP1 expression. J Biol Chem 281: 21119-21130.
19. Montminy M, Brindle P, Arias J, Ferreri K, Armstrong R. (1996). Regulation of somatostatin gene transcription by cyclic adenosine monophosphate. Metabolism 45: 4-7.
20. Mullan PB, Quinn JE, Harkin DP. (2006). The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene 25: 5854-5863.
21. Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K et al. (2004). Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23: 2385-2400.
22. Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM. (2000). CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci USA 97: 1020-1025.
23. Paull TT, Cortez D, Bowers B, Elledge SJ, Gellert M. (2001). Direct DNA binding by Brca1. Proc Natl Acad Sci USA 98: 6086-6091.
24. Rosen EM, Fan S, Ma Y. (2006). BRCA1 regulation of transcription. Cancer Lett 236: 175-185.
25. Rosen EM, Fan S, Pestell RG, Goldberg ID. (2003). BRCA1 gene in breast cancer. J Cell Physiol 196: 19-41.
26. Ruffner H, Jiang W, Craig AG, Hunter T, Verma IM. (1999). BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol Cell Biol 19: 4843-4854.
27. Santiago F, Clark E, Chong S, Molina C, Mozafari F, Mahieux R et al. (1999). Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J Virol 73: 9917-9927.
28. Soni R, Muller L, Furet P, Schoepfer J, Stephan C, Zumstein-Mecker S et al. (2000). Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product. Biochem Biophys Res Commun 275: 877-884.
29. Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, Quinn AG. (2002). FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 62: 4773-4780.
30. Wang C, Fan S, Li Z, Fu M, Rao M, Ma Y et al. (2005). Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Res 65: 6557-6567.
31. Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN. (1997). BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15: 143-157.
32. Zheng L, Annab LA, Afshari CA, Lee WH, Boyer TG. (2001). BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc Natl Acad Sci USA 98: 9587-9592.